U.S. Supreme Court Denies Certiorari In FCA Public Disclosure Bar Dispute

( October 7, 2024, 1:57 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 7 denied a petition for certiorari filed by pharmaceutical companies seeking review of the Ninth Circuit U.S. Court of Appeals’ ruling that the public disclosure bar was not triggered in a case where it reversed a district court’s dismissal of a suit accusing the companies of violating the False Claims Act (FCA) by artificially inflating drug prices....

U.S. Supreme Court Denies Certiorari In FCA Public Disclosure Bar Dispute

Attached Documents

Related Sections